interest
respiratori
virus
increas
recent
due
identif
sever
new
virus
threat
pose
other
abl
cross
interspeci
barrier
sever
respiratori
acut
syndrom
sra
avian
influenza
merscov
introduct
molecular
approach
mainstay
diagnosi
viral
respiratori
tract
infect
serolog
viru
isol
cell
cultur
immunofluoresc
assay
techniqu
low
sensit
detect
limit
number
virus
sensit
time
requir
obtain
result
improv
recent
develop
molecular
test
also
detect
virus
previous
undetect
coronavirus
bocavirus
use
test
also
demonstr
carriag
respiratori
virus
rare
adult
recent
develop
new
multiplex
pcr
test
mpcr
facilit
rapid
detect
broad
rang
respiratori
virus
clinic
specimen
increasingli
use
howev
test
expens
yet
taken
account
regul
guidelin
wide
use
nevertheless
use
alreadi
improv
descript
epidemiolog
respiratori
virus
variou
highrisk
popul
neonat
preterm
infant
children
immunocompromis
patient
elderli
gener
adult
popul
recent
studi
shown
viral
pathogen
detect
patient
attend
emerg
depart
acut
respiratori
symptom
communityacquir
pneumonia
icu
respiratori
virus
detect
patient
communityacquir
pneumonia
nosocomi
pneumonia
associ
high
mortal
rate
howev
studi
publish
date
subject
sever
limit
base
differ
method
detect
respiratori
virus
perform
specif
popul
often
winter
object
studi
retrospect
describ
epidemiolog
respiratori
virus
use
mpcr
adult
hospit
franc
fiveyear
period
result
present
season
type
clinic
unit
patient
age
group
respiratori
tract
region
involv
respiratori
sampl
adult
patient
year
old
test
respiratori
virus
request
physician
may
april
includ
studi
retrospect
hospit
group
encompass
five
hospit
beaujon
bichatclaud
bernard
loui
mourier
bretonneau
hautval
locat
pari
area
three
intens
care
unit
emerg
infecti
diseas
intern
gener
medicin
depart
two
geriatr
hospit
nasopharyng
swab
bronchial
aspir
bronchoalveolar
lavag
place
virocult
mwe
sigma
st
loui
mo
usa
transport
medium
transport
virolog
laboratori
bichatclaud
bernard
hospit
repeat
sampl
defin
sampl
taken
part
respiratori
tract
upper
lower
patient
month
discard
accord
french
ethic
rule
epidemiolog
surveil
studi
rule
place
aphp
assist
de
pari
obtain
nonopposit
patient
hospit
admiss
sever
differ
mpcr
test
use
studi
period
maastricht
netherland
may
februari
maastricht
netherland
march
decemb
ii
seoul
south
korea
januari
april
june
april
filmarray
respiratori
panel
biofir
diagnost
salt
lake
citi
usa
also
use
respons
specif
request
rapid
diagnosi
physician
intens
care
unit
pneumolog
unit
chang
test
use
time
made
decreas
time
result
none
test
could
differenti
rhinoviru
enteroviru
two
type
viru
therefor
group
togeth
picornaviru
rhinoviru
enteroviru
purpos
analysi
test
account
test
includ
analysi
detect
bocavirus
variou
test
use
report
similar
perform
confirm
intern
comparison
method
valid
reliabl
also
assess
throughout
studi
period
qcmd
control
glasgow
uk
compar
distribut
viral
find
month
sampl
ii
area
respiratori
tract
sampl
upper
lower
iii
type
medic
unit
iv
patient
age
sampl
area
defin
upper
respiratori
tract
urt
nasopharyng
swab
aspir
lower
respiratori
tract
lrt
bronchial
aspir
bronchoalveolar
lavag
four
group
prescrib
unit
defin
accord
section
hospit
intens
care
unit
icu
pneumolog
unit
lung
transplant
unit
unit
unit
mostli
emerg
depart
infecti
diseas
intern
medicin
nephrolog
geriatr
unit
patient
stratifi
sever
age
group
year
year
year
year
year
test
fisher
exact
test
perform
r
softwar
use
comparison
group
appropri
test
perform
type
error
monthli
cumul
result
viral
distribut
across
studi
period
depict
tabl
fig
cumul
number
sampl
frequenc
posit
test
higher
novemb
april
period
extend
late
fall
earli
spring
refer
period
winter
period
frequenc
posit
test
virus
higher
winter
period
summer
period
vs
p
expect
distribut
virus
differ
two
period
fig
p
distribut
influenza
follow
typic
season
pattern
observ
europ
activ
circul
januari
march
rsv
coronaviru
metapneumoviru
bocaviru
also
frequent
detect
winter
period
circul
extend
novemb
may
two
group
virus
circul
throughout
year
picornaviru
parainfluenza
viru
togeth
two
group
account
virus
detect
summer
period
picornavirus
constitut
second
frequent
group
virus
winter
influenza
adenoviru
complex
season
pattern
year
cover
studi
rare
adult
circul
throughout
year
caus
epidem
exclus
winter
area
respiratori
tract
sampl
indic
sampl
sampl
came
urt
came
lrt
result
depict
fig
tabl
urt
frequent
sampl
winter
vs
lrt
p
posit
rate
higher
urt
lrt
vs
p
distribut
viral
group
differ
significantli
urt
lrt
p
three
frequent
viral
group
urt
influenza
picornaviru
coronaviru
frequent
viral
group
lrt
picornaviru
parainfluenza
influenza
rsv
result
obtain
sampl
type
medic
unit
record
depict
fig
tabl
posit
rate
differ
significantli
type
medic
unit
p
rang
icu
lung
transplant
unit
distribut
virus
also
differ
type
medic
unit
p
picornavirus
frequent
group
icu
pneumolog
unit
lung
transplant
unit
contrast
medic
unit
influenza
picornaviru
account
virus
respect
proport
sampl
obtain
winter
differ
significantli
type
medic
unit
lung
transplant
unit
icu
pneumolog
unit
medic
unit
p
consist
greater
focu
viru
identif
influenza
epidem
infect
lrt
area
repres
sever
infect
rate
sampl
part
respiratori
tract
constant
year
therefor
analyz
viral
distribut
type
medic
unit
separ
lrt
sampl
fig
lrt
sampl
posit
rate
icu
pneumolog
unit
lung
transplant
unit
unit
preval
influenza
higher
icu
type
unit
versu
p
picornaviru
group
frequent
viral
group
unit
frequenc
rang
virus
detect
icu
lung
transplant
medic
unit
group
posit
rate
differ
significantli
age
group
rang
p
howev
distribut
virus
differ
age
group
fig
tabl
p
picornavirus
account
virus
identifi
age
group
group
virus
frequent
extrem
age
group
consid
year
influenza
frequent
respect
analysi
urt
lrt
sampl
separ
fig
show
influenza
less
frequent
lrt
urt
age
group
picornaviru
group
group
virus
frequent
detect
lrt
sampl
age
group
sampl
test
correspond
viral
coinfect
six
coinfect
involv
three
virus
proport
virus
identifi
coinfect
differ
group
influenza
picornaviru
parainfluenza
metapneumoviru
rsv
coronaviru
adenoviru
bocaviru
p
group
virus
seem
abl
exist
alongsid
virus
coinfect
preferenti
associ
respiratori
virus
identifi
burden
respiratori
virus
well
establish
children
exampl
recent
describ
global
epidemiolog
respiratori
virus
children
treat
hospit
group
found
broadrang
detect
provid
multiplex
pcr
greatli
improv
detect
respiratori
virus
thu
understand
epidemiolog
also
found
differ
children
adult
also
report
group
especi
influenza
interest
respiratori
virus
present
adult
popul
also
increas
howev
mani
previou
studi
focus
exclus
winter
period
influenza
detect
may
underestim
potenti
role
respiratori
virus
canadian
studi
perform
canada
nation
hospit
databas
show
influenza
respiratori
virus
associ
morbid
requir
hospit
children
adult
popul
studi
also
describ
high
frequenc
noninfluenza
virus
adult
hospit
china
spain
franc
howev
due
differ
popul
age
group
climat
condit
sampl
laboratori
method
incid
season
respiratori
virus
may
differ
slightli
countri
studi
moreov
limit
data
avail
distribut
respiratori
virus
lower
respiratori
tract
retrospect
studi
one
largest
studi
europ
provid
broad
snapshot
epidemiolog
respiratori
virus
hospit
set
fiveyear
period
base
result
mpcr
test
studi
sampl
test
posit
least
one
respiratori
viru
nasopharyng
sampl
collect
mostli
winter
period
posit
rate
slightli
lower
report
previou
clinic
studi
base
mpcr
test
nasopharyng
sampl
posit
rate
rang
differ
explain
use
strict
case
definit
link
prospect
aspect
studi
wherea
studi
retrospect
may
repres
real
condit
hospit
unit
lower
respiratori
tract
sampl
constant
frequenc
throughout
year
posit
rate
nonneglig
find
consist
previou
studi
pneumonia
case
admit
icu
posit
rate
rang
interestingli
main
viral
group
identifi
lrt
sampl
also
neglect
picornaviru
group
group
virus
lead
group
present
lrt
patient
age
group
type
medic
unit
identifi
virus
role
picornaviru
pneumonia
increasingli
studi
commonli
thought
picornavirus
caus
common
cold
associ
rare
ever
sever
pneumonia
detect
virus
group
case
sever
pneumonia
must
reflect
asymptomat
carriag
howev
despit
frequent
detect
picornavirus
asymptomat
children
recent
studi
shown
asymptomat
carriag
respiratori
virus
includ
picornavirus
rare
asymptomat
adult
also
suggest
virus
group
better
adapt
urt
infect
lrt
infect
replic
vitro
effect
howev
experiment
picornaviru
infect
restrict
urt
also
detect
lrt
may
also
associ
increas
number
bacteria
classic
associ
secondari
infect
bacteri
microbiota
account
predisposit
bacteri
otiti
media
sinus
pneumonia
confer
picornaviru
picornavirus
known
associ
asthma
exacerb
chronic
obstruct
pulmonari
diseas
also
implic
directli
develop
asthma
previou
studi
reveal
associ
specif
subtyp
picornavirus
greater
pathogen
immunocompromis
patient
importantli
picornavirus
increasingli
associ
commun
hospitalacquir
sever
pneumonia
studi
viral
pneumonia
frequent
found
associ
picornavirus
display
nonneglig
pathogen
complic
clinic
cours
coinfect
involv
bacteria
virus
huge
predomin
picornavirus
lrt
observ
studi
also
highlight
potenti
role
virus
sever
pneumonia
pathogen
group
virus
also
increasingli
describ
parainfluenza
identifi
second
frequent
group
virus
lrt
studi
also
recent
associ
mortal
rate
immunocompromis
patient
death
per
year
patient
age
year
netherland
studi
influenza
rare
highli
vaccin
popul
lung
transplant
recipi
highli
preval
older
patient
find
highlight
need
increas
vaccin
rate
elderli
inde
despit
object
vaccin
rate
atrisk
popul
franc
popul
effect
vaccin
studi
influenza
also
highli
preval
urt
lrt
patient
age
year
suggest
popul
present
less
sever
diseas
due
viru
nevertheless
play
major
role
drive
influenza
epidem
also
suggest
popul
children
previou
studi
mpcr
test
abl
fulli
discrimin
influenza
subtyp
data
obtain
other
indic
similar
distribut
subtyp
describ
correspond
period
franc
data
shown
studi
sever
limit
due
retrospect
natur
includ
virolog
epidemiolog
data
therefor
possibl
assess
clinic
impact
respiratori
virus
nosocomi
commun
origin
potenti
associ
bacteria
anoth
limit
absenc
intern
nation
uniform
local
recommend
concern
use
mpcr
local
case
definit
requir
mpcr
may
chang
account
gradual
increas
number
test
perform
studi
period
first
year
last
thu
data
avail
concern
number
suspect
case
test
mpcr
although
lower
global
posit
rate
observ
previou
studi
may
suggest
test
wide
use
physician
hospit
group
concern
picornaviru
group
none
mpcr
test
discrimin
rhinoviru
enteroviru
subtyp
strong
robust
thu
assess
current
work
differenti
distribut
pathogen
within
larg
viral
group
specif
studi
need
preval
bocaviru
group
clearli
underestim
studi
virus
detect
respifind
test
total
number
sampl
test
howev
bocavirus
found
rare
adult
popul
account
virus
identifi
last
limit
chang
mpcr
test
use
laboratori
studi
period
chang
made
aim
shorten
time
requir
obtain
result
work
hour
test
h
less
h
test
chang
may
introduc
bia
viral
distribut
despit
good
yeartoyear
reproduc
result
local
assess
mpcr
perform
introduct
test
mani
aspect
burden
respiratori
virus
hospit
set
remain
investig
pediatr
popul
respiratori
viru
pathogen
well
demonstr
viral
group
rapid
mpcr
assay
shown
improv
detect
respiratori
virus
decreas
time
requir
obtain
result
therebi
make
possibl
decreas
durat
antibiot
treatment
time
spent
emerg
depart
adult
evid
pathogen
respiratori
virus
increasingli
evidenc
antibiot
treatment
often
continu
posit
pcr
test
virus
even
normal
chest
radiographi
studi
new
recommend
therefor
requir
today
recent
studi
pave
way
futur
larg
trial
report
halv
durat
antibiot
treatment
diagnost
strategi
base
pct
mpcr
test
respiratori
virus
also
present
burden
hospit
set
risk
nosocomi
infect
influenza
test
current
perform
epidem
period
isol
infect
patient
use
specif
treatment
recommend
patient
isol
case
infect
respiratori
virus
unclear
despit
recent
studi
show
viral
infect
neither
frequent
uncommon
patient
sever
hospitalacquir
pneumonia
larger
studi
requir
determin
need
enlarg
viral
detect
patient
isol
measur
noninfluenza
virus
adult
children
conclus
despit
increas
acknowledg
pathogen
respiratori
virus
extens
assess
virus
still
rare
clinic
practic
high
cost
mpcr
test
ii
absenc
specif
treatment
vaccin
except
influenza
iii
reluct
stop
antibiot
treatment
adult
howev
high
rate
posit
obtain
studi
reallif
hospit
set
highlight
larg
burden
infect
particularli
true
group
virus
larg
neglect
picornavirus
current
research
effort
focu
princip
develop
vaccin
drug
influenza
rsv
larg
prospect
studi
includ
clinic
observ
bacteri
investig
much
need
assess
pathogen
picornavirus
noninfluenza
respiratori
virus
precis
well
evalu
establish
new
recommend
manag
hospit
set
